Literature DB >> 19857497

Neurofilament ELISA validation.

Axel Petzold1, Ayse Altintas, Laura Andreoni, Ales Bartos, Achim Berthele, Marinus A Blankenstein, Luc Buee, Massimiliano Castellazzi, Sabine Cepok, Manuel Comabella, Cris S Constantinescu, Florian Deisenhammer, Gunnur Deniz, Gaye Erten, Mercedes Espiño, Enrico Fainardi, Diego Franciotta, Mark S Freedman, Vilmantas Giedraitis, Nils Erik Gilhus, Gavin Giovannoni, Andrzej Glabinski, Pawel Grieb, Hans-Peter Hartung, Bernhard Hemmer, Sanna-Kaisa Herukka, Rogier Hintzen, Martin Ingelsson, Samuel Jackson, Steve Jacobsen, Naghmeh Jafari, Marcin Jalosinski, Sven Jarius, Elisabeth Kapaki, Bernd C Kieseier, Marleen J A Koel-Simmelink, Johannes Kornhuber, Jens Kuhle, Jacek Kurzepa, Patrice H Lalive, Lars Lannfelt, Vera Lehmensiek, Piotr Lewczuk, Paolo Livrea, Fabiana Marnetto, Davide Martino, Til Menge, Niklas Norgren, Eva Papuć, George P Paraskevas, Tuula Pirttilä, Cecília Rajda, Konrad Rejdak, Jan Ricny, Daniela Ripova, Lars Rosengren, Maddalena Ruggieri, Susanna Schraen, Gerry Shaw, Christian Sindic, Aksel Siva, Torgny Stigbrand, Iva Stonebridge, Baris Topcular, Maria Trojano, Hayrettin Tumani, Harry A M Twaalfhoven, László Vécsei, Vincent Van Pesch, Hugo Vanderstichele, Christian Vedeler, Marcel M Verbeek, Luisa Maria Villar, Robert Weissert, Brigitte Wildemann, Cui Yang, Karen Yao, Charlotte E Teunissen.   

Abstract

BACKGROUND: Neurofilament proteins (Nf) are highly specific biomarkers for neuronal death and axonal degeneration. As these markers become more widely used, an inter-laboratory validation study is required to identify assay criteria for high quality performance.
METHODS: The UmanDiagnostics NF-light (R)enzyme-linked immunoabsorbent assays (ELISA) for the neurofilament light chain (NfL, 68kDa) was used to test the intra-assay and inter-laboratory coefficient of variation (CV) between 35 laboratories worldwide on 15 cerebrospinal fluid (CSF) samples. Critical factors, such as sample transport and storage, analytical delays, reaction temperature and time, the laboratories' accuracy and preparation of standards were documented and used for the statistical analyses.
RESULTS: The intra-laboratory CV averaged 3.3% and the inter-laboratory CV 59%. The results from the test laboratories correlated with those from the reference laboratory (R=0.60, p<0.0001). Correcting for critical factors improved the strength of the correlation. Differences in the accuracy of standard preparation were identified as the most critical factor. Correcting for the error introduced by variation in the protein standards improved the correlation to R=0.98, p<0.0001 with an averaged inter-laboratory CV of 14%. The corrected overall inter-rater agreement was subtantial (0.6) according to Fleiss' multi-rater kappa and Gwet's AC1 statistics.
CONCLUSION: This multi-center validation study identified the lack of preparation of accurate and consistent protein standards as the main reason for a poor inter-laboratory CV. This issue is also relevant to other protein biomarkers based on this type of assay and will need to be solved in order to achieve an acceptable level of analytical accuracy. The raw data of this study is available online. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19857497     DOI: 10.1016/j.jim.2009.09.014

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  30 in total

1.  Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.

Authors:  Alessandra Gaiani; Ilaria Martinelli; Luca Bello; Giorgia Querin; Marco Puthenparampil; Susanna Ruggero; Elisabetta Toffanin; Annachiara Cagnin; Chiara Briani; Elena Pegoraro; Gianni Sorarù
Journal:  JAMA Neurol       Date:  2017-05-01       Impact factor: 18.302

2.  Data quality in drug discovery: the role of analytical performance in ligand binding assays.

Authors:  Hermann Wätzig; Imke Oltmann-Norden; Franziska Steinicke; Hassan A Alhazmi; Markus Nachbar; Deia Abd El-Hady; Hassan M Albishri; Knut Baumann; Thomas Exner; Frank M Böckler; Sami El Deeb
Journal:  J Comput Aided Mol Des       Date:  2015-06-13       Impact factor: 3.686

3.  Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis.

Authors:  Antonio Scarafino; Eustachio D'Errico; Alessandro Introna; Angela Fraddosio; Eugenio Distaso; Irene Tempesta; Antonella Morea; Antonella Mastronardi; Rosaria Leante; Maddalena Ruggieri; Mariangela Mastrapasqua; Isabella Laura Simone
Journal:  J Neurol       Date:  2018-08-16       Impact factor: 4.849

Review 4.  The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.

Authors:  Martin Stangel; Sten Fredrikson; Edgar Meinl; Axel Petzold; Olaf Stüve; Hayrettin Tumani
Journal:  Nat Rev Neurol       Date:  2013-03-26       Impact factor: 42.937

5.  Protein aggregate formation permits millennium-old brain preservation.

Authors:  Axel Petzold; Ching-Hua Lu; Mike Groves; Johan Gobom; Henrik Zetterberg; Gerry Shaw; Sonia O'Connor
Journal:  J R Soc Interface       Date:  2020-01-08       Impact factor: 4.118

6.  Plasma clusterin levels in predicting the occurrence of coronary artery lesions in patients with Kawasaki disease.

Authors:  Hong-Ren Yu; Ho-Chang Kuo; Eng-Yen Huang; Chi-Di Liang; Kao-Pin Hwang; I-Chun Lin; Jiunn-Ming Sheen; Tzu-Jou Wang; Chih-Lu Wang; Kuender D Yang
Journal:  Pediatr Cardiol       Date:  2010-08-15       Impact factor: 1.655

7.  N-acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis.

Authors:  Alessandro Trentini; Manuel Comabella; Mar Tintoré; Marleen J A Koel-Simmelink; Joep Killestein; Birthe Roos; Alex Rovira; Carsten Korth; Philipp Ottis; Marinus A Blankenstein; Xavier Montalban; Tiziana Bellini; Charlotte E Teunissen
Journal:  J Neurol       Date:  2014-09-17       Impact factor: 4.849

Review 8.  Neurofilaments: neurobiological foundations for biomarker applications.

Authors:  Arie R Gafson; Nicolas R Barthélemy; Pascale Bomont; Roxana O Carare; Heather D Durham; Jean-Pierre Julien; Jens Kuhle; David Leppert; Ralph A Nixon; Roy O Weller; Henrik Zetterberg; Paul M Matthews
Journal:  Brain       Date:  2020-07-01       Impact factor: 13.501

9.  A comparison of Cohen's Kappa and Gwet's AC1 when calculating inter-rater reliability coefficients: a study conducted with personality disorder samples.

Authors:  Nahathai Wongpakaran; Tinakon Wongpakaran; Danny Wedding; Kilem L Gwet
Journal:  BMC Med Res Methodol       Date:  2013-04-29       Impact factor: 4.615

10.  CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.

Authors:  M Khalil; C Enzinger; C Langkammer; S Ropele; A Mader; A Trentini; M L G Vane; M Wallner-Blazek; G Bachmaier; J-J Archelos; M J A Koel-Simmelink; M A Blankenstein; S Fuchs; F Fazekas; C E Teunissen
Journal:  Mult Scler       Date:  2012-08-23       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.